British tech company Oxford Nanopore outlines medium-term growth plans

British technology company Oxford Nanopore said it hoped to reach break-even by the end of 2026, as it outlined plans to drive further growth in the life science research tools market and expand into new areas of healthcare. Oxford Nanopore, a spinout from the University of Oxford which floated two years ago, wants to further commercialise its sensing technology which is able to produce immediate analysis of DNA and RNA for use across scientific research, healthcare and other industries. "Today also marks an important transition for Oxford Nanopore as we introduce our medium-to-long term strategy to meet unmet needs in the clinical and applied markets," Chief Executive Gordon Sanghera said in a statement.